Partners
Nordic Bioscience
Expertise Partner
Nordic Bioscience is a Danish biomarker company headquartered in Herlev, Denmark. Nordic Bioscience is engaged in biomarker development using our unique neoepitope technology. We combine our expertise in biomarker development with preclinical and clinical research. This enables us to develop biomarkers that provide fast and objective decision-making for compound selection and development in clinical trials as well as provide value for patients in a diagnostic setting.
FibroFind
Expertise Partner
FibroFind is a rapidly developing biomedical sciences company that has a deep understanding of fibrosis biology and has employed this knowledge to design bespoke biological assays with human tissues that can determine if a novel drug is able to prevent fibrosis and halt disease. The business focus for FibroFind is their proprietary human fibrosis bioassays in Precision Cut Tissue Slices that provide a pre-clinical service for pharmaceutical and biotechnology companies developing medicines that target inflammation or fibrosis. Despite only beginning trading 3 years ago, FibroFind has already contributed towards new medicines entering into ongoing clinical trials.
Newcells Biotech
Innovation Partner
Newcells Biotech is a fast-growing team of global scientific and industry experts based in state of the art facilities in the Helix Science Campus of Newcastle-upon-Tyne in the UK. Our purpose is to bridge the gap between scientific discovery and patients and we make a difference by providing better predictions of clinical outcomes. Using our expertise in induced pluripotent stem cells (iPSCs), cellular physiology and organoid technology, we build functional pre-clinical in vitro models of kidney, retina, liver and lung.
Aragen Biosciences
Exhibition Partner
Aragen Life Sciences is a leading R&D and manufacturing solutions provider for the life sciences industries worldwide. Aragen offers end-to-end integrated or standalone solutions to advance small and large molecule programs from concept to commercialization. Established in 2001, the Company operates through a global network of six sites with a team of 3800+ employees and 450+ PhDs. Its expertise and experience have enabled over 450 customers (including 7 of the top 10 pharma companies globally) in advancing their research programs from early discovery through development and commercialization. Aragen’s innovative mindset, infrastructure, flexible business models, a clear purpose, and proprietary project management platform have enabled it to effectively scale and service large pharma, biotech, agrochemical, and animal health industries globally.
Biomodels LLC
Exhibition Partner
Biomodels LLC, a preclinical CRO, conducts predictive and translational studies for biotechnology and pharmaceutical companies in the areas of fibrosis, pulmonary and inflammatory diseases, in addition to several other clinical indications. Biomodels specializes in (non-GLP) customized efficacy studies that optimize dose, schedule, and define mechanism of action. Additionally, Biomodels' state of the art Germ-Free and Gnotobiotic animal facility allows for the analysis of the role of the microbiota both in disease pathogenesis and in therapeutic efficacy.
Gubra
Event Partner
Gubra is a specialized CRO and R&D company. Gubra’s main focus is on preclinical studies and peptide-based drug discovery within metabolic and fibrotic diseases, including metabolic dysfunction-associated steatohepatitis (MASH, formerly known as nonalcoholic steatohepatitis or NASH), chronic kidney disease (CKD), idiopathic pulmonary fibrosis (IPF), inflammatory bowel disease (IBD) and cardiovascular disease (CVD). Gubra is industry-leading in translational animal models and applies state-of-the art technology platforms centered around AI-enabled automation and digitalization to ensure fast-track objective analysis, high-quality data and conclusive study results.